Candesartan and Hydrochlorothiazide |
Atacand HCT |
Candesartan and Hydrochlorothiazide News Headlines
- Lupin Receives Final Approval For Lisinopril-HCTZ Tablets
MedicalNewsToday - Fri, 29 Sep 2006 07:00 EST
- Incidence Of Atrial Fibrillation Significantly Reduced By Candesartan Therapy In Heart Failure Patients
MedicalNewsToday - Sun, 16 Jul 2006 06:00 EST
- Incidence Of Atrial Fibrillation Significantly Reduced By Atacand® Therapy In Heart Failure Patients
MedicalNewsToday - Mon, 10 Jul 2006 06:00 EST
- FDA Approves Higher Dose Formulations Of Diovan HCT(R) (valsartan/hydrochlorothiazide) For Treatment Of High Blood Pressure
MedicalNewsToday - Tue, 02 May 2006 06:00 EST
- Novel Study Published In New England Journal Of Medicine Evaluates Effects Of ATACAND(R) (candesartan Cilexetil) In Patients With Prehypertension
MedicalNewsToday - Fri, 21 Apr 2006 06:00 EST
- Candesartan therapy can reduce the risk of diabetes in heart failure patients
MedicalNewsToday - Sun, 10 Jul 2005 08:00 EST
- Cardesartan Helps Improve Subjective Symptoms in Heart Failure Patients, Large-Scale CHARM Study
MedicalNewsToday - Tue, 07 Jun 2005 10:00 EST
- Heart failure patients perceive improvement in symptoms on Atacand® treatment
MedicalNewsToday - Sat, 04 Jun 2005 05:00 EST
- First large-scale international clinical programme for treatment of diabetic retinopathy
MedicalNewsToday - Wed, 01 Jun 2005 06:00 EST
- Benicar and Benicar HCT significantly reduces systolic hypertension, study
MedicalNewsToday - Fri, 27 May 2005 06:00 EST
- FDA Approves Atacand for Use with an ACE Inhibitor in the Treatment of Heart Failure
MedicalNewsToday - Sun, 22 May 2005 01:00 EST
- FDA Approves HYZAAR® as First/Only Fixed-Dose Combination Hypertension Medicine to Help Prevent Stroke in Patients
MedicalNewsToday - Sun, 15 May 2005 07:00 EST
- For Patients with Hypertension and Left Ventricular Hypertrophy, FDA Approves HYZAAR®
MedicalNewsToday - Sun, 17 Apr 2005 06:00 EST

Not Signed In -


